Annual report regarding the study A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis in Nordic Countries.

Mikkel Zöllner Ankarfeldt; Janne Petersen; Espen Jimenez Solem

Annual report regarding the study A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis in Nordic Countries.

Mikkel Zöllner Ankarfeldt, Janne Petersen, Espen Jimenez Solem

Original language	English

Publisher	Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark
Publication status	Published - 2020

Cite this

Ankarfeldt, M. Z., Petersen, J., & Jimenez Solem, E. (2020). Annual report regarding the study A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis in Nordic Countries. Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.

Annual report regarding the study A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis in Nordic Countries. / Ankarfeldt, Mikkel Zöllner ; Petersen, Janne ; Jimenez Solem, Espen.

Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, 2020.

Research output: Book/Report › Report › Research

Ankarfeldt, MZ , Petersen, J & Jimenez Solem, E 2020, Annual report regarding the study A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis in Nordic Countries. Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.

Ankarfeldt MZ , Petersen J , Jimenez Solem E. Annual report regarding the study A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis in Nordic Countries. Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, 2020.

Ankarfeldt, Mikkel Zöllner ; Petersen, Janne ; Jimenez Solem, Espen. / Annual report regarding the study A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis in Nordic Countries. Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, 2020.

@book{b9c0f4dcd951449e9adf2a26fb888a55,

title = "Annual report regarding the study A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis in Nordic Countries.",

author = "Ankarfeldt, {Mikkel Z{\"o}llner} and Janne Petersen and {Jimenez Solem}, Espen",

year = "2020",

language = "English",

publisher = "Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark",

}

TY - RPRT

T1 - Annual report regarding the study A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis in Nordic Countries.

AU - Ankarfeldt, Mikkel Zöllner

AU - Petersen, Janne

AU - Jimenez Solem, Espen

PY - 2020

Y1 - 2020

M3 - Report

BT - Annual report regarding the study A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis in Nordic Countries.

PB - Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark

ER -